Patents by Inventor Ewald Aydt
Ewald Aydt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10683453Abstract: The present invention relates to soluble organic compounds, to compositions comprising these compounds, to formulations comprising the compounds or compositions, and to electronic devices.Type: GrantFiled: November 18, 2015Date of Patent: June 16, 2020Assignee: Merck Patent GmbHInventors: Amir Hossain Parham, Philipp Stoessel, Christof Pflumm, Anja Jatsch, Joachim Kaiser, Ewald Aydt, Dominik Joosten
-
Patent number: 10130827Abstract: The present invention relates, inter alia, to dermal systems comprising at least one light source and at least one pharmaceutically and/or cosmetically active ingredient. The dermal systems can be employed in order to enhance the penetration and action of the pharmaceutically and/or cosmetically active ingredient.Type: GrantFiled: January 11, 2017Date of Patent: November 20, 2018Assignee: Merck Patent GmBhInventors: Herwig Buchholz, Ewald Aydt, Junyou Pan
-
Publication number: 20170369773Abstract: The present invention relates to soluble organic compounds, to compositions comprising these compounds, to formulations comprising the compounds or compositions, and to electronic devices.Type: ApplicationFiled: November 18, 2015Publication date: December 28, 2017Inventors: Amir Hossain PARHAM, Philipp STOESSEL, Christof PFLUMM, Anja JATSCH, Joachim KAISER, Ewald AYDT, Dominik JOOSTEN
-
Publication number: 20170182333Abstract: The present invention relates, inter alia, to dermal systems comprising at least one light source and at least one pharmaceutically and/or cosmetically active ingredient. The dermal systems can be employed in order to enhance the penetration and action of the pharmaceutically and/or cosmetically active ingredient.Type: ApplicationFiled: January 11, 2017Publication date: June 29, 2017Inventors: Herwig BUCHHOLZ, Ewald AYDT, Junyou PAN
-
Publication number: 20170100607Abstract: The present invention relates inter alia to functional materials for the treatment and/or prophylaxis and/or diagnosis of diseases and/or cosmetic conditions. The functional materials can be used for the preparation of light emitting devices comprising fibers as light emitting elements.Type: ApplicationFiled: December 23, 2016Publication date: April 13, 2017Inventors: Junyou PAN, Herwig BUCHHOLZ, Ewald AYDT
-
Patent number: 9597527Abstract: Described is a dermal system which contains at least one light source and at least one pharmaceutically and/or cosmetically active ingredient. The dermal system can be employed in order to enhance the penetration and action of the pharmaceutically and/or cosmetically active ingredient. The at least one light source is a thin light source comprising at least one inorganic light emitting diode (LEDs) and/or at least one organic light emitting device.Type: GrantFiled: June 20, 2011Date of Patent: March 21, 2017Assignee: Merck Patent GmbHInventors: Herwig Buchholz, Ewald Aydt, Junyou Pan
-
Patent number: 9539438Abstract: The present invention relates inter alia to functional materials for the treatment and/or prophylaxis and/or diagnosis of diseases and/or cosmetic conditions. The functional materials can be used for the preparation of light emitting devices comprising fibers as light emitting elements.Type: GrantFiled: February 15, 2011Date of Patent: January 10, 2017Assignee: Merck Patent GmbHInventors: Junyou Pan, Herwig Buchholz, Ewald Aydt
-
Patent number: 9492681Abstract: The present invention relates to a cells and cell tissue treatment device and use thereof.Type: GrantFiled: January 16, 2012Date of Patent: November 15, 2016Assignee: Merck Patent GmbHInventors: Ewald Aydt, Herwig Buchholz, Junyou Pan
-
Publication number: 20160256053Abstract: The present invention relates inter alia to light emitting fibers for the application in general lighting, display backlit, information display, and for treatment and/or prophylaxis and/or diagnosis of diseases and/or cosmetic conditions. The fibers can be used for the preparation of any kind of canvas and light emitting devices.Type: ApplicationFiled: May 17, 2016Publication date: September 8, 2016Inventors: Junyou PAN, Ewald AYDT, Herwig BUCHHOLZ
-
Patent number: 9373807Abstract: The present invention relates inter alia to light emitting fibers for the application in general lighting, display backlit, information display, and for treatment and/or prophylaxis and/or diagnosis of diseases and/or cosmetic conditions. The fibers can be used for the preparation of any kind of canvas and light emitting devices.Type: GrantFiled: February 15, 2011Date of Patent: June 21, 2016Assignee: Merck Patent GmbHInventors: Junyou Pan, Herwig Buchholz, Ewald Aydt
-
Publication number: 20140148877Abstract: The present invention relates inter alia to compositions comprising ionic species and electroluminescent compounds, formulations and devices comprising them, and their use for the treatment and/or prophylaxis of therapeutic diseases and/or cosmetic conditions.Type: ApplicationFiled: January 2, 2014Publication date: May 29, 2014Applicant: Merck Patent GmbHInventors: Junyou Pan, Herwig Buchholz, Ewald Aydt
-
Publication number: 20130324909Abstract: The present invention relates to a cells and cell tissue treatment device and use thereof.Type: ApplicationFiled: January 16, 2012Publication date: December 5, 2013Applicant: Merck Patent GmbHInventors: Ewald Aydt, Herwig Buchholz, Junyou Pan
-
Patent number: 8461207Abstract: Pharmaceutical compositions comprising at least one compound of the formula (I) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols and substituents have the following meaning —X— is e.g. and Y being e.g. or the pharmaceutically acceptable salts, esters or amides and prodrugs can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or selectin binding.Type: GrantFiled: February 23, 2011Date of Patent: June 11, 2013Assignee: Revotar Biopharmaceuticals AGInventors: Ewald Aydt, Remo Kranich
-
Publication number: 20130116616Abstract: The present invention relates, inter alia, to dermal systems comprising at least one light source and at least one pharmaceutically and/or cosmetically active ingredient. The dermal systems can be employed in order to enhance the penetration and action of the pharmaceutically and/or cosmetically active ingredient.Type: ApplicationFiled: June 20, 2011Publication date: May 9, 2013Applicant: MERCK PATENT GMBHInventors: Herwig Buchholz, Ewald Aydt, Junyou Pan
-
Patent number: 8394835Abstract: Pharmaceutical compositions comprising at least one compound of the formulas (Ia) or (Ib) and a pharmaceutically acceptable carrier wherein the symbols have the following meaning —X— is e.g. and Y being e.g. or the pharmaceutically acceptable salts can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or L-selectin binding.Type: GrantFiled: March 1, 2011Date of Patent: March 12, 2013Assignee: Revotar Biopharmaceuticals AGInventors: Ewald Aydt, Remo Kranich, Anke Busemann
-
Publication number: 20130006118Abstract: The present invention relates inter alia to light emitting fibers for the application in general lighting, display backlit, information display, and for treatment and/or prophylaxis and/or diagnosis of diseases and/or cosmetic conditions. The fibers can be used for the preparation of any kind of canvas and light emitting devices.Type: ApplicationFiled: February 15, 2011Publication date: January 3, 2013Applicant: MERCK PATENT GMBHInventors: Junyou Pan, Herwig Buchholz, Ewald Aydt
-
Publication number: 20130006119Abstract: The present invention relates inter alia to functional materials for the treatment and/or prophylaxis and/or diagnosis of diseases and/or cosmetic conditions. The functional materials can be used for the preparation of light emitting devices comprising fibers as light emitting elements.Type: ApplicationFiled: February 11, 2011Publication date: January 3, 2013Applicant: MERCK PATENT GMBHInventors: Junyou Pan, Herwig Buchholz, Ewald Aydt
-
Patent number: 8278356Abstract: Pharmaceutical compositions comprising at least one compound of the formula (I) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols and substituents have the following meaning —X— is e.g. and Y being e.g. or the pharmaceutically acceptable salts, esters or amides and prodrugs can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or selectin binding.Type: GrantFiled: February 23, 2011Date of Patent: October 2, 2012Assignee: Revotar Biopharmaceuticals AGInventors: Ewald Aydt, Remo Kranich
-
Publication number: 20120245658Abstract: The present invention relates inter alia to compositions comprising ionic species and electroluminescent compounds, formulations and devices comprising them, and their use for the treatment and/or prophylaxis of therapeutic diseases and/or cosmetic conditions.Type: ApplicationFiled: November 11, 2010Publication date: September 27, 2012Applicant: Merck Patent GmbHInventors: Junyou Pan, Herwig Buchholz, Ewald Aydt